Delivery Order SPE2DB20D9127-SPE2DB24FPRR3

Award Date 9/27/24
Potential Completion Date 10/21/24
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $44,087.00 firm fixed-price delivery order for the supply of 4,555,937,918 units of Botox 100 unit vials. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to...
This federal contract award, valued at $11,101.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,567,994,800 units of Botox 100 unit vials, with a completion date of April 23, 2025. The award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,845.92 contract is for the supply of BOTOX 100 unit vials, with a period of performance through August 8, 2024. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999. The...
This federal contract award, valued at $13,844.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,564,828,313 units of Botox 100 unit vials, with a period of performance through June 27, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the United States Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,613.28 firm fixed-price delivery order is for the supply of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities worldwide. The contract is part of a larger $499,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,614.80 firm fixed-price delivery order is for the supply of 4,564,376,400 units of Botox 100 unit vials, with a completion date of May 13, 2024. This award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award, valued at $4,614.80, was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical supplier based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials, with an ultimate completion date of April 22, 2024. This award appears to be a delivery order issued under a larger indefinite delivery vehicle (IDV) contract, contract # SPE2DB, that DMS Pharmaceutical...
This federal contract award, valued at $11,101.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,567,937,906 units of Botox 100 unit vials, with a completion date of May 2, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This federal contract award was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,307.40, is a firm fixed-price delivery order for the supply of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), under the agency's Medical Supply Chain division. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that...
This federal contract award, valued at $5,277.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026. The delivery order is for 4,558,277,483 units of Botox 100 unit vials. As a key supplier in the...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB24FPRR3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $55,377.60 firm fixed-price delivery order is for the supply of 4,565,984,531 units of Botox 100 unit vials, with a period of performance through October 21, 2024.

The contract is not associated with a set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business allows the company to secure direct federal awards across a range of pharmaceutical products. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers the supply of a comprehensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide.

Generated 2/27/25, 11:31 AM